The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 27, 2017
Filed:
Dec. 11, 2015
Applicant:
Galecto Biotech Ab, Copenhagen, DK;
Inventors:
Tariq Sethi, Haddington, GB;
Alison Mackinnon, Edinburgh, GB;
Hakon Leffler, Lund, SE;
Ulf Nilsson, Lund, SE;
Assignee:
Galecto Biotech AB, Copenhagen, DK;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07H 19/056 (2006.01); C07H 3/04 (2006.01); G01N 33/68 (2006.01); A61K 9/00 (2006.01); A61K 31/7008 (2006.01); C07H 5/10 (2006.01); A61M 15/00 (2006.01);
U.S. Cl.
CPC ...
C07H 19/056 (2013.01); A61K 9/0075 (2013.01); A61K 9/0078 (2013.01); A61K 31/7008 (2013.01); C07H 3/04 (2013.01); C07H 5/10 (2013.01); G01N 33/6893 (2013.01); A61M 15/0085 (2013.01); A61M 2202/064 (2013.01); C07B 2200/13 (2013.01); G01N 2333/4724 (2013.01); G01N 2800/122 (2013.01);
Abstract
Provided is a compound of the general formula (I): The compound of formula (I) is suitable for treating pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a mammal. Also provided is a method for treatment of pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a human subject having a galectin-3 level indicative of pulmonary fibrosis or exacerbation of symptoms as well as a method for making said compound.